VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.
Pharmacogenomics and Pharmacotherapy
Last Updated: 2026-02-05 15:05:21
Abstract
The aim of the course is to give an overview of the traditional field of pharmacogenetics, which focuses on the polymorphisms of distinct genes, and to introduce the expanding potential of pharmacogenomics which encompasses the entire genome from which the multifactorial complexity of drug response unfolds.
Objective
A large proportion of a drug's therapeutic efficacy, or lack thereof, arises from the recipient's genetic makeup. Novel high-speed technologies for the identification of inter-individual genetic variations are already enhancing drug development, and customizing therapy to an individual's genomic signature is becoming feasible. The aim of the course is to give an overview of the traditional field of pharmacogenetics, which focuses on the polymorphisms of distinct genes, and to introduce the expanding potential of pharmacogenomics which encompasses the entire genome from which the multifactorial complexity of drug response unfolds.
Content
Topics to be covered include molecular genomic techniques, genetics, biodiversity and population studies including the HapMap project, genetic disease disposition, drug responses and their sources of variability, new drug targets, clinical drug development, individualized drug therapy, toxicogenomics, and social and ethical aspects.
General Information
- Language
- English
- Levels
- MSC
- Frequency
- Yearly recurring
Examination
- Type
- session examination
- Mode
- written 60 minutes
- Aids
- None
Course Components
| Type | Title | Time & Place | Hours |
|---|---|---|---|
| lecture with exercise | Pharmacogenomics and Pharmacotherapy |
|
3 h weekly |